@article {168149,
	title = {Potential therapeutic effects of induced pluripotent stem cells on induced salivary gland cancer in experimental rats.},
	journal = {Biotechnic \& histochemistry : official publication of the Biological Stain Commission},
	year = {2018},
	month = {2018 Oct 19},
	pages = {1-8},
	abstract = {<p>Salivary gland neoplasms exhibit complex histopathology in a variety of tumor types and treatment options depend largely on the stage of the cancer. Induced pluripotent stem cells (iPS) have been investigated for treating induced salivary gland cancer and for restoring salivary gland function. We investigated iPS treatment for salivary gland cancer both in vitro and in vivo. For our study in vitro, we re-programmed human skin fibroblasts to form iPS cells using a plasmid containing Oct4, Sox2, L-MYC and LIN28. For our study in vivo, we used 30 white male albino rats divided into the following groups of 10: group 1 (control): rats were injected with phosphate-buffered saline (PBS), group 2 induced squamous cell carcinoma (SCC): rat submandibular glands were injected with squamous carcinoma cells (SCC), group 3 (induced SCC/iPS): SCC treated rats treated with 5~{\texttimes}~106 iPS cells. Submandibular glands from rats of all groups were examined histologically and real time PCR was performed for amylase, and COX I and COX II gene expression. We confirmed that submandibular gland specimens included tumor tissue before starting treatment with iPS. iPS treated cases exhibited regeneration of salivary glands, although minor degenerative and vascularization changes remained. The acinar cells regained their proper organization, but continued to exhibit abnormal activity including hyperchromatism. iPS cells may be useful for treating salivary gland carcinomas.</p>
},
	issn = {1473-7760},
	doi = {10.1080/10520295.2018.1508747},
	author = {Alaa El-Din, Yasmine and Dina Sabry and Abdelrahman, Amal Hassan and Safa Fathy}
}
